Iovance Biotherapeutics, Inc. (IOVA)
Iovance Biotherapeutics Market Cap : 1.030B for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Lantheus Holdings, Inc. | 4.462B |
| Plus Therapeutics, Inc. | 37.15M |
| BioStem Technologies, Inc. | 92.21M |
| Protokinetix, Inc. | 3.250M |
| GB Sciences, Inc. | 0.1628M |
Market Cap Related Metrics
| PS Ratio | 3.436 |
| Price to Book Value | 1.467 |
| Price | 2.595 |
| Earnings Yield | -46.32% |